Combined Use of Ruxolitinib and Sirolimus: Increased Monitoring of Triglycerides Required
Overview
Affiliations
Fachin A, De Carlo C, Maestro A, Zanon D, Barbi E, Maximova N Pharmaceuticals (Basel). 2023; 16(8).
PMID: 37630982 PMC: 10457918. DOI: 10.3390/ph16081069.
Guha A, Stabellini N, Montero A Front Cardiovasc Med. 2022; 9:962698.
PMID: 36017091 PMC: 9395698. DOI: 10.3389/fcvm.2022.962698.
Haematological Drugs Affecting Lipid Metabolism and Vascular Health.
Parrella A, Iannuzzi A, Annunziata M, Covetti G, Cavallaro R, Aliberti E Biomedicines. 2022; 10(8).
PMID: 36009482 PMC: 9405726. DOI: 10.3390/biomedicines10081935.
Etiology and Management of Dyslipidemia in Patients With Cancer.
de Jesus M, Mohammed T, Singh M, Tiu J, Kim A Front Cardiovasc Med. 2022; 9:892335.
PMID: 35548413 PMC: 9081373. DOI: 10.3389/fcvm.2022.892335.